Management and prognosis of multiple sclerosis-Reference-Cited by-同舟云学术

Management and prognosis of multiple sclerosis

Published:2011-11 Issue:Sup11 Volume:72 Page:M174-M176
ISSN:1750-8460
Container-title:British Journal of Hospital Medicine
language:en
Short-container-title:British Journal of Hospital Medicine

Author:

Hassan-Smith Ghaniah¹,Douglas Michael R²

Affiliation:

1. Centre for Translational Inflammation Research, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham B15 2WB

2. University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham and Department of Neurology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley

Publisher

Mark Allen Group

Subject

General Medicine

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2011.72.Sup11.M174

Reference12 articles.

1. The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis

2. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

3. Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

4. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

5. Long-term follow-up of clinical trials of multiple sclerosis therapies

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutical growth in oligodendroglial fate induction via transdifferentiation of stem cells for neuroregenerative therapy;Biochimie;2023-08

2. Next-generation version of recombinant human interferon-beta: A molecular dynamic simulation study;Informatics in Medicine Unlocked;2022

3. A review of possible therapies for multiple sclerosis;Molecular and Cellular Biochemistry;2021-04-22

4. Role of Ginkgolides in the Inflammatory Immune Response of Neurological Diseases: A Review of Current Literatures;Frontiers in Systems Neuroscience;2020-07-31

5. Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4+ T cell apoptosis;Journal of Neuroinflammation;2020-05-06